Stay up to date with notifications from The Independent

Notifications can be managed in browser preferences.

Scientific breakthrough could enable paralysed people to walk again

Researchers plan to be able to create personalised implants to repair tissue damaged from injury.

Nina Massey
Monday 07 February 2022 05:15 EST
Scientists created spinal cord implants that could enable paralysed people to walk (Sagol Centre for Regenerative Biotechnology/PA)
Scientists created spinal cord implants that could enable paralysed people to walk (Sagol Centre for Regenerative Biotechnology/PA)

Your support helps us to tell the story

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.

At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.

The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.

Your support makes all the difference.

A scientific breakthrough may enable paralysed people to walk again as researchers have created human spinal cord implants in a world first.

The 3D implants, made using human cells, had an 80% success rate in restoring the ability to walk in paralysed mice in the laboratory, researchers said.

Tissue samples from patients are transformed into functioning spinal cord implants through a process that mimics the development of the spinal cord in human embryos.

Over the next few years the scientists plan to be able to create personalised implants to repair tissue damaged from injury, and without the risk of rejection by the body.

They are preparing for clinical trials in humans and hope that in the coming years the engineered tissues will be implanted into paralysed people enabling them to stand up and walk again.

Our goal is to produce personalised spinal cord implants for every paralysed person, enabling regeneration of the damaged tissue with no risk of rejection

Professor Tal Dvir

The study was led by Professor Tal Dvir’s research team at the Sagol Centre for Regenerative Biotechnology, the Shmunis School of Biomedicine and Cancer Research, and the Department of Biomedical Engineering at Tel Aviv University.

Prof Dvir said: “The model animals underwent a rapid rehabilitation process, at the end of which they could walk quite well.

“This is the first instance in the world in which implanted engineered human tissues have generated recovery in an animal model for long-term chronic paralysis – which is the most relevant model for paralysis treatments in humans.

“There are millions of people around the world who are paralysed due to spinal injury, and there is still no effective treatment for their condition.

“Individuals injured at a very young age are destined to sit in a wheelchair for the rest of their lives, bearing all the social, financial, and health-related costs of paralysis.

“Our goal is to produce personalised spinal cord implants for every paralysed person, enabling regeneration of the damaged tissue with no risk of rejection.”

Professor Tal Dvir (Sagol Centre for Regenerative Biotechnology/PA)
Professor Tal Dvir (Sagol Centre for Regenerative Biotechnology/PA)

Prof Dvir explained that the technology is based on taking a small biopsy of belly fat tissue from the patient.

The researchers used genetic engineering to reprogramme the cells and return them to a state that resembles embryonic stem cells – the cells capable of becoming any type of cell in the body.

Prof Dvir added that the researchers hope to reach the stage of clinical trials in humans within the next few years – and ultimately get these patients back on their feet – and said they have good reason to expect relatively rapid approval of our technology.

The findings are published in Advanced Science.

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in